Prevalence of Plasmodium falciparum isolates lacking the histidine rich protein 2 gene among symptomatic malaria patients in Kwilu Province of the Democratic Republic of Congo.


Journal

Infectious diseases of poverty
ISSN: 2049-9957
Titre abrégé: Infect Dis Poverty
Pays: England
ID NLM: 101606645

Informations de publication

Date de publication:
25 May 2021
Historique:
received: 22 01 2021
accepted: 13 05 2021
entrez: 26 5 2021
pubmed: 27 5 2021
medline: 26 11 2021
Statut: epublish

Résumé

Malaria rapid diagnostic tests have become a primary and critical tool for malaria diagnosis in malaria-endemic countries where Plasmodium falciparum Histidine Rich Protein 2-based rapid diagnostic tests (PfHRP2-based RDTs) are widely used. However, in the last decade, the accuracy of PfHRP2-based RDTs has been challenged by the emergence of P. falciparum strains harbouring deletions of the P. falciparum histidine rich protein 2 (pfhrp2) gene, resulting in false-negative results. In the Democratic Republic of Congo (D.R. Congo), little is known about the prevalence of the pfhrp2 gene deletion among P. falciparum isolates infecting symptomatic patients, especially in low to moderate transmission areas where pfhrp2 deletion parasites are assumed to emerge and spread. Here we determine the local prevalence and factors associated with pfhrp2 gene deletions among symptomatic malaria patients in the Kwilu Province of the D.R. Congo. We used secondary data from a prospective health facility-based cross-sectional study conducted in 2018. Blood was collected for microscopy, PfHRP2-RDT, and spotted onto Whatman filter paper for downstream genetic analysis. Genomic DNA was extracted and used to perform PCR assays for the detection and confirmation of pfhrp2 gene deletions. Fischer's exact and the Kruskal-Wallis tests were applied to look for associations between potential explanatory variables and the pfhrp2 gene deletion with a level of statistical significance set at P < 0.05. Of the 684 enrolled symptomatic patients, 391 (57.7%) were female. The majority (87.7%) reported the presence of mosquito breeding sites within the household's compound, and fever was the most reported symptom (81.6%). The overall prevalence of the pfhrp2 gene deletion was 9.2% (95% CI: 6.7%-12.1%). The deletion of the pfhrp2 gene was associated with health zone of origin (P = 0.012) and age (P = 0.019). Among false-negative PfHRP2-RDT results, only 9.9% were due to pfhrp2 gene deletion. P. falciparum isolates with pfhrp2 gene deletions are relatively common among symptomatic patients in Kwilu province. Further investigations are needed to provide enough evidence for policy change. Meanwhile, the use of RDTs targeting PfHRP2 and parasite lactate dehydrogenase (pLDH) antigens could limit the spread of deleted isolates.

Sections du résumé

BACKGROUND BACKGROUND
Malaria rapid diagnostic tests have become a primary and critical tool for malaria diagnosis in malaria-endemic countries where Plasmodium falciparum Histidine Rich Protein 2-based rapid diagnostic tests (PfHRP2-based RDTs) are widely used. However, in the last decade, the accuracy of PfHRP2-based RDTs has been challenged by the emergence of P. falciparum strains harbouring deletions of the P. falciparum histidine rich protein 2 (pfhrp2) gene, resulting in false-negative results. In the Democratic Republic of Congo (D.R. Congo), little is known about the prevalence of the pfhrp2 gene deletion among P. falciparum isolates infecting symptomatic patients, especially in low to moderate transmission areas where pfhrp2 deletion parasites are assumed to emerge and spread. Here we determine the local prevalence and factors associated with pfhrp2 gene deletions among symptomatic malaria patients in the Kwilu Province of the D.R. Congo.
METHODS METHODS
We used secondary data from a prospective health facility-based cross-sectional study conducted in 2018. Blood was collected for microscopy, PfHRP2-RDT, and spotted onto Whatman filter paper for downstream genetic analysis. Genomic DNA was extracted and used to perform PCR assays for the detection and confirmation of pfhrp2 gene deletions. Fischer's exact and the Kruskal-Wallis tests were applied to look for associations between potential explanatory variables and the pfhrp2 gene deletion with a level of statistical significance set at P < 0.05.
RESULTS RESULTS
Of the 684 enrolled symptomatic patients, 391 (57.7%) were female. The majority (87.7%) reported the presence of mosquito breeding sites within the household's compound, and fever was the most reported symptom (81.6%). The overall prevalence of the pfhrp2 gene deletion was 9.2% (95% CI: 6.7%-12.1%). The deletion of the pfhrp2 gene was associated with health zone of origin (P = 0.012) and age (P = 0.019). Among false-negative PfHRP2-RDT results, only 9.9% were due to pfhrp2 gene deletion.
CONCLUSIONS CONCLUSIONS
P. falciparum isolates with pfhrp2 gene deletions are relatively common among symptomatic patients in Kwilu province. Further investigations are needed to provide enough evidence for policy change. Meanwhile, the use of RDTs targeting PfHRP2 and parasite lactate dehydrogenase (pLDH) antigens could limit the spread of deleted isolates.

Identifiants

pubmed: 34034827
doi: 10.1186/s40249-021-00860-1
pii: 10.1186/s40249-021-00860-1
pmc: PMC8146217
doi:

Substances chimiques

Antigens, Protozoan 0
Histidine 4QD397987E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

77

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 16K21233 and 19K07526

Références

Malar J. 2017 Mar 20;16(1):123
pubmed: 28320390
Elife. 2019 May 02;8:
pubmed: 31045490
Acta Trop. 2019 Aug;196:121-125
pubmed: 31103699
Am J Trop Med Hyg. 2012 Feb;86(2):194-8
pubmed: 22302847
Clin Microbiol Infect. 2019 May;25(5):580-585
pubmed: 30267926
Infect Genet Evol. 2017 Nov;55:131-134
pubmed: 28889944
PLoS One. 2017 Mar 16;12(3):e0171150
pubmed: 28301474
PLoS One. 2016 Aug 12;11(8):e0157949
pubmed: 27518538
J Infect Dis. 2017 Apr 1;215(7):1156-1166
pubmed: 28329034
J Infect Dis. 2018 Feb 14;217(5):685-692
pubmed: 29220497
Malar J. 2011 Mar 24;10:67
pubmed: 21435256
Acta Trop. 2013 Jan;125(1):119-21
pubmed: 23041541
PLoS One. 2012;7(8):e43094
pubmed: 22952633
Malar J. 2015 Oct 29;14:420
pubmed: 26511932
Sci Rep. 2017 Nov 7;7(1):14718
pubmed: 29116127
Malar J. 2018 Apr 2;17(1):137
pubmed: 29609602
Acta Trop. 2015 Dec;152:26-31
pubmed: 26297799
Malar J. 2018 Aug 31;17(1):320
pubmed: 30170596
PLoS One. 2015 May 15;10(5):e0126805
pubmed: 25978499
Malar J. 2013 Jan 24;12:34
pubmed: 23347727
PLoS One. 2016 Sep 16;11(9):e0163137
pubmed: 27636709
Med Sante Trop. 2013 May 1;23(2):181-4
pubmed: 23774584
Malar J. 2017 Nov 09;16(1):456
pubmed: 29121931
PLoS One. 2015 Jul 07;10(7):e0131576
pubmed: 26151448
Am J Trop Med Hyg. 2017 Oct;97(4):1155-1158
pubmed: 28820682
J Infect Dis. 2017 Jul 1;216(1):36-44
pubmed: 28177502
Am J Trop Med Hyg. 2019 Apr;100(4):842-845
pubmed: 30719965
Malar J. 2014 Jul 22;13:283
pubmed: 25052298
Malar J. 2017 Oct 16;16(1):416
pubmed: 29037193
Malar J. 2015 Jan 21;14:19
pubmed: 25604310
Elife. 2017 Oct 16;6:
pubmed: 29034876
Malar J. 2016 Feb 18;15:101
pubmed: 26891848
PLoS One. 2010 Jan 25;5(1):e8091
pubmed: 20111602
BMJ. 2004 Nov 20;329(7476):1212
pubmed: 15542534
Malar J. 2018 Oct 29;17(1):394
pubmed: 30373573
Sci Rep. 2013 Sep 30;3:2797
pubmed: 24077522
J Med Microbiol. 2013 Oct;62(Pt 10):1491-1505
pubmed: 24048274
Malar J. 2014 Jan 29;13:34
pubmed: 24472178

Auteurs

Yannick Bazitama Munyeku (YB)

Direction Des Laboratoires de Santé, Ministère de La Santé, Kinshasa, Democratic Republic of the Congo. ymunyeku@gmail.com.
Institut National de Recherche Biomédicale (INRB), Laboratoire de Virologie Clinique, Kinshasa, Democratic Republic of the Congo. ymunyeku@gmail.com.
Graduate School of Tropical Medicine and Global Health (TMGH), Nagasaki University, Nagasaki, Japan. ymunyeku@gmail.com.
Malaria Unit, Department of Pathology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. ymunyeku@gmail.com.

Alain Abera Musaka (AA)

Division Provinciale de La Santé du Kwilu, Kwilu, Democratic Republic of the Congo.
Institut Supérieur Des Techniques Médicales (ISTM), Kikwit, DR, Congo.

Medard Ernest (M)

Malaria Unit, Department of Pathology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA.

Chris Smith (C)

Graduate School of Tropical Medicine and Global Health (TMGH), Nagasaki University, Nagasaki, Japan.
Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.

Paul Mankadi Mansiangi (PM)

Kinshasa School of Public Health, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Richard Culleton (R)

Graduate School of Tropical Medicine and Global Health (TMGH), Nagasaki University, Nagasaki, Japan. culleton.richard.oe@ehime-u.ac.jp.
Malaria Unit, Department of Pathology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. culleton.richard.oe@ehime-u.ac.jp.
Department of Protozoology, Institute of Tropical Medicine (NEKKEN), Nagasaki, Japan. culleton.richard.oe@ehime-u.ac.jp.
Division of Molecular Parasitology, Proteo-Science Centre, Ehime University, Toon, Japan. culleton.richard.oe@ehime-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH